Differential activation of p53 targets in cells treated with ultraviolet radiation that undergo both apoptosis and growth arrest

Radiation Research

Volumn 148, Issue 2, 1997, Pages 115-122

  Reinke, Valerie ^a   Lozano, Guillermina ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; DNA DAMAGE; FEMALE; NONHUMAN; PRIORITY JOURNAL; RADIATION HAZARD; RAT; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 0030748598     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579567     Document Type: Article

References (52)

1. P. Hainaut, T. Soussi, B. Shomer, M. Hollstein, M. Greenblatt, E. Harg, C. C. Harris and R. Montesano, Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acids Res. 25, 151-157 (1997).
2. L. J. Ko and C. Prives, p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
3. L. Raycroft, H. Wu and G. Lozano, Transcriptional activation of wild type but not transforming mutants of the p53 anti-oncogene. Science 249, 1049-1051 (1990).
4. Y. Cho, S. Gorina, P. D. Jeffrey and N. P. Pavletich, Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265, 346-355 (1994).
5. S. E. Kern, J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler and B. Vogelstein, Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830 (1992).
6. L. Raycroft, J. R. Schmidt, K. Yoas, M. Hao and G. Lozano, Analysis of p53 mutants for transcriptional activity. Mol. Cell. Biol. 11, 6067-6074 (1992).
7. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
8. X. Lu and D. P. Lane, Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75, 765-778 (1993).
9. W. Maltzman and L. Czyzyk, UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4, 1689-1694 (1984).
10. M. B. Kastan, Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein and A. J. Fornace, Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
11. E. Yonish-Rouach, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi and M. Oren, Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991).
12. A. R. Clarke, C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper and A. H. Wyllie, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
13. S. W. Lowe, E. M. Schmitt, S. W. Smith, B. A. Osborne and T. Jacks, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
14. X. Chen, L. J. Ko, L. Jayaraman and C. Prives, p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-2451 (1996).
15. H. Symonds, L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks and T. Van Dyke, p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711 (1994).
16. C. E. Canman, T. M. Gilmer, S. B. Coutts and M. B. Kastan, Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9, 600-611 (1995).
17. W. S. El-Deiry, T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
18. J. W. Harper, G. R. Adami, N. Wei, K. Keyomarsi and S. J. Elledge, The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
19. Y. Xiong, G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi and D. Beach, p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 (1993).
20. J. Brugarolas, C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks and G. J. Hannon, Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552-557 (1993).
21. C. Deng, P. Zhang, J. W. Harper, S. J. Elledge and P. Leder. Mice lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
22. J. D. Oliner, K. W. Kinzler, P. S. Meltzer, D. L. George and B. Vogelstein, Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83 (1992).
23. J. Momand, G. P. Zambetti, D. C. Olson, D. George and A. J. Levine, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
24. Y. Barak, T. Juven, R. Haffner and M. Oren, mdm2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
25. X. Wu, J. H. Bayle, D. Olson and A. J. Levine, The p53-mdm2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132 (1993).
26. S. N. Jones, A. E. Roe, L. A. Donehower and A. Bradley, Rescue of early embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378, 206-208 (1995).
27. R. Montes de Oca Luna, D. S. Wagner and G. Lozano, Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206 (1995).
28. Z. N. Oltvai, C. L. Milliman and S. J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
29. T. Miyashita and J. C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
30. K. Tamura, Y. Kanaska, S. Jinno, A. Nataga, Y. Ogiso and K. Shimizu, Cyclin G: a new mammalian homolog with homology to fission yeast Cig1. Oncogene 8, 2113-2118 (1993).
31. K. Okamoto and D. Beach, Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13, 4816-4822 (1994).
32. A. Zauberman, A. Lupo and M. Oren, Identification of p53 target genes through immune selection of genomic DNA; the cyclin G gene contains two distinct p53 binding sites. Oncogene 10, 2361-2366 (1995).
33. cip1/waf1 proteins following γ-irradiation of human lymphoma cells. Cancer Res. 55, 2387-2393 (1995).
34. C. Chen and H. Okayama, High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).
35. A. Deffie, M. Hao, R. Montes de Oca Luna, D. L. Hulboy and G. Lozano, Cyclin E restores activity in contact-inhibited cells. Mol. Cell. Biol. 15, 3926-3933 (1995).
36. P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
37. S. E. Kern, K. W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives and B. Vogelstein, Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711 (1991).
38. M. E. Perry, J. Piette, J. A. Zawadzki, D. Harvey and A. J. Levine, The mdm2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 90, 11623-11627 (1993).
39. ++-mediated endonuclease activation. Science 242, 256-259 (1988).
40. J. J. Ryan, R. Danish, C. A. Gottlieb and M. F. Clarke, Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol. 13, 711-719 (1993).
41. P. Michieli, M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer and D. Givol, Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395 (1994).
42. K. F. Macleod, N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein and T. Jacks, p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev. 9, 935-944 (1995).
43. H. Jiang, J. Lin, Z-Z. Su, F. R. Collart, E. Huberman and P. B. Fisher, Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9, 3397-3406 (1994).
44. R. A. Steinman, B. Hoffman, A. Iro, C. Guillouf, D. A. Lieberman and M. E. El-Houseini, Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 9, 3389-3396 (1994).
45. K. M. McMasters, R. Montes de Oca Luna, J. R. Pena and G. Lozano, mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts. Oncogene 13, 1731-1736 (1996).
46. Z-M. Yuan, Y. Huang, Y. Whang, C. Sawyers, R. Weichselbaum, S. Kharbanda and D. Kufe, Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382, 272-274 (1996).
47. Y. Terada, M. Tatsuka, S. Jinno and H. Okayama, Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376, 358-362 (1995).
48. T. Haapajarvi, L. Kivinen, K. Pitkanen and M. Laiho, Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. Oncogene 11, 151-159 (1995).
49. C. M. Knudson, K. S. K. Tung, W. G. Tourtellote, G. A. J. Brown and S. J. Korsmeyer, Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
50. X. Lu, S. A. Burbidge, S. Griffin and H. M. Smith, Discordance between accumulated p53 protein level and its transcriptional activity in response to U.V. radiation. Oncogene 13, 413-418 (1996).
51. S. Tommasi, P. M. Swiderski, Y. Tu, B. E. Kaplan and G. P. Pfeifer, Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry 35, 15693-15703 (1996).
52. M. Ljungman and F. Zhang, Blockage of RNA polymerase as a possible trigger for u. v. light-induced apoptosis. Oncogene 13, 823-831 (1996).